Index

Note: Page numbers followed by B bladder (urinary) dysfunction, 66–68

f indicates figure and t indicates table. acupuncture, 68
back pain in choreoathetoid cerebral
electrical stimulation, 68
palsy, case study, 87–88
key patterns, 67, 67t
A Back Shu (Huatuojiaji) points, 29
management, 68
baclofen, 63, 175
acquired immunodeficiency syndrome in multiple sclerosis, 66
ballism, 63
(AIDS), 163 overactive, in multiple sclerosis, case
Barthel ADL Index, 104
activities of daily living (ADL), 104 study, 91–92
Beck Depression Inventory (BDI),
agitation secondary to pain in stroke, in Parkinson’s disease, 66
201
case study, 94–95 prevalence, 66
belching, 13
alcoholic peripheral neuropathy, 55 in stroke, 66, 105
Bell’s palsy, 22, 167
allodynia, 169 Blazing Gan Fire, 9
acupuncture, 168
alteplase, 103 Blood
acute, case study, 168–169
Alzheimer’s disease, 127 Heart (Xin) and, 6
causes, 167
amantadine, 127 Spleen and, 10
differential diagnosis, 167
amenorrhoea, 9 stagnation, 22
’flash cupping, 196
American Spinal Injuries Association storage of, 9
medical treatment, 167
(ASIA) Impairment Scale, Bobath techniques, 116–118
physiotherapy, 167–168
152–153, 152t body acupuncture
benign essential (familial)
amitryptyline, 56, 175 in motor neurone disease, 177
tremor, 22
amyotrophic lateral sclerosis (ALS), in multiple sclerosis, 141
benzodiazepines, 72, 175
126, 174 in Parkinson’s disease, 129
Berg Balance Scale, 84–85
ancestor worship, 4 in spinal cord injury, 155
Bi syndrome, 15–18
anger, 11–12 Bone/Kidney Bi, 20
bony, 18
antimuscarinics, 68 bony Bi, 18
cold invasion, 17
anxiety, 11–12, 74 suggested points, 18
damp invasion, 17
acupuncture for, 77t botulinum toxin (BTX or BoNT), 63,
heat, 17
following traumatic brain injury, 103, 175
origin of pain from, 16f
case study, 94 bowel dysfunction, 68–71
progression from external to internal,
stroke and, 105 acupuncture, 69t, 71, 72t
18f
apoptosis, 102 electrical stimulation, 71
wind invasion (Wind Bi), 16
arteriosclerotic parkinsonism, 126 key patterns, 68–69
biofeedback, 106
arteriosclerotic pseudoparkinsonism, 126 management, 69–71
biopsychosocial model, 40
aspirin, 102–103 in multiple sclerosis, 68
bladder
asthma, 26 in Parkinson’s disease, 68
neural control, 66f
atropine, 175 prevalence, 68
spinal cord control, 67t
autonomic dysreflexia, 153
 Index
bowel function
spinal cord control of, 71t
in stroke, 68
Brain (Nao) (sea of Marrow), 15, 16t
brain imaging, 33f
breathing problems in motor neurone
disease, 176
Brown-Séquard syndrome, 152
pain from active trigger point,
case study, 86
C in motor neurone disease, 176
cancer, 46
capacity for consent, 44
carbidopa, 127
carpal tunnel syndrome, 26, 58
cauda equina syndrome, 153
central cord syndrome, 152
central poststroke pain (CPSP), 113,
115–116
cerebellar disease, 22
cerebral palsy, 116
acupressure, 118
acupuncture, 58, 117–118
bowel problems in, 68
case study: back pain and abnormal
posture, 118
choreoathetoid, back and hip pain in,
case study, 87–88
physiotherapy and, 116–117
prognosis, 116
symptoms, 116
treatment, 116
cerebrovascular accident (CVA), 100
see also stroke
cervical myelopathy, insomnia in, case
study, 92–93
cholecystitis, 13
chorea, 63
chronic disease management, 43–44
expert patient, 43
self-management programmes, 43–44
chronic fatigue syndrome, 21
Clear Qi, 7
clinical governance, 44
clinical reasoning, 27–34
course of treatment, 95
depth of needling, 95
framework, 84, 85t
selection of points, 95
stimulation, 95
clinical stroke syndromes, 101
clumsy hand syndrome, 102
206
Cochrane review protocols, 198 dysaesthesia, 58
cognitive-behavioural therapy, 56 acupuncture for, 58, 61t
cognitive loss in multiple sclerosis, 140 in transverse myelitis, case study,
cold Bi invasion, 17 86–87
suggested points, 17 dysarthria
computed tomography in stroke, 102 in motor neurone disease, 176
consent, 35–36, 44 in multiple sclerosis, 140
Consolidated Standards for Reporting of dyskinesia, 58
Trials (CONSORT) organization, and ‘off’ symptoms in Parkinson’s
27 disease, case study, 91
constipation dysmenorrhoea, 9
drug-induced, 13 dystonia, 63
in multiple sclerosis, case study, 92
in stroke, 68–69
E
conus medullaris syndrome, 153 ear acupuncture, 188–192
Corporeal Soul (Hun), 8 research, 191–192
Curious Organs, 15 technique, 191
cystitis, 14 ear charts, Chinese, 189, 190f
Eastern acupuncture, 195–199
blood stagnation points, 196t
D ideas and techniques, 195–196
damp invasion, 17 neurology syndrome,
suggested points, 17 197–199, 198f
Dan (Gall Bladder), paralysing fear and, Qi vs Blood stagnation, 195, 196t
11–12 electroacupuncture (EA), 29, 33–34,
deafness, Kidneys and, 11 193
deep-brain stimulation, 127 application, 193
deep-vein thrombosis (DVT), 153 contraindications, 193–194
defaecation dyssynergia, 68–69 in neurological conditions, 193
dementia, 101, 127 safety, 193–194
demonology, 4 in stroke, 107, 107f
dental pain, postoperative, 26 see also Eastern acupuncture;
depression, 74 Western clinical acupuncture
acupuncture for, 76t electromyography, 163
in multiple sclerosis, 140 evidence-based medicine, 27–29
case study, 93–94 External Pathogens, 15
in Parkinson’s disease, 127 eye, Liver and, 9
Deqi, 55
dermatome, 29
patterns, 33f
F
detrusor areflexia (hypocontractility), 67 F-wave test, 63
detrusor hyperreflexia, 67 faecal incontinence in stroke, 105
detrusor-sphincter dyssynergia, 67 falls, stroke and, 105
dexterity, impaired, in stroke case familial tremor, 22
study, 88 fatigue, 73
diabetes mellitus as risk factor for acupuncture for, 73, 74t
stroke, 101 management, 73
diabetic neuropathy, 166 in motor neurone disease, 176
background, 166 in multiple sclerosis, case
research, 166 study, 93
dropped-head syndrome, 126 in neurological conditions, 73
dry needling, 192 physiotherapy, 46
Dupuytren’s fracture, 18 prevalence, 73
 Index

Fatigue Impact Scale (FIS), 201 headache, 26 K

fear, paralysing, 11–12 health governance, 44
Feng syndromes, 22 Heart (Xin), 6–7 Kennedy’s disease, 174
points for, 22t Heart 7 (Shenmen), 6 KI 3 (Taixi), 12
fibromyalgia, 26, 46, 73 Heat Bi, 17 Kidney (Shen), 10–12
fight or flight response, 11–12 suggested points, 17–18 deficiencies, 20–22
fingernails, Liver and, 9 hemiparesis, 104 heart and, 7
Fire, 14 hemiplegia, 100, 104 Kidney Yin Xu, 20
‘Fire of the Gate of Vitality’, 10–11 heparin, 102–103
Five-Element theory (Worsley), 4, hepatitis, 13 L
10–11 herpes zoster virus, 169–170
lacunar infarcts (LACIs), 102
fixed Bi, 17 hip pain in choreoathetoid cerebral
Large Intestine (Da Change), 12–13
frontal lobe tumours, 22 palsy, case study, 87–88
levodopa, 63, 127
Fu organs, 12–15 hiccups, 13
Liver (Gan), 6, 8–9
Fu Xi, 5 historical development, 4–5
deficiencies, 20–22
Fugl–Meyer Assessment (FMA), 201 Hmax/Mmax ratio, 63
‘Liver invading Spleen’, 9
functional electrical stimulation, 106 Hoffman Reflex (H-Reflex), 63,
Liver Qi and Yang Xu, 21–22
functional magnetic resonance 201–202
Liver Yin Xu, 20–21
imaging, 28, 58 Huang Di Nei Jing, 4
low-back pain, 26
human immunodeficiency virus
lower-body parkinsonism, 126
(HIV), 163
G Lower Jiao (Drainage Ditch), 14
LU 7 (Lieque), 8
Gall Bladder (Dan), 13, 15
gapapentin, 56
I Lungs (Fei), 7–8

General Health Questionnaire-12 incidence of neurological

(GHQ-12), 94, 201
GHQ-60, 201
glycopyrrolate, 175
gout, 126
Governing Vessel (Du meridian), 7
Gua Sha, 197, 197f
Guam variant MND, 174
Guillain-Barré syndrome (GBS), 55,
162
acupuncture, 163–164
bladder dysfunction in, 66
case studies, 166, 167
damage to motor nerves, 163
damage to sensory nerves, 162–163
diagnosis, 163
physiotherapy, 163
prevalence of urinary problems,
66
symptoms, 162–163
TCM theories, 164–165
deficient Spleen Qi, 164
deficient Spleen yang, 164–165
H jealousy, 14
H-Reflex, 63, 201–202
hair, Kidneys and, 11
Hamilton Rating Scale for Depression
(HAM-D), 201
conditions, 40
Incontinence Impact Questionnaire
(IIQ-7) score, 91
insomnia, 71–73
acupuncture for, 73
in cervical myelopathy, case study,
92–93
Liver and, 9
management, 72
in motor neurone disease, 176
multiple sclerosis and, 46–47
in neurological conditions, 72
in Parkinson’s disease, 72
physiotherapy, 46–47
prevalence, 72
Insomnia Severity Index (ISI), 202
interferon, 139
International Classification of
Functioning, Disability and
Health (ICF), 40–41, 104, 104t
J and Rotting; Chamber of
jaundice, 13
Jin Ye circulation, 8f
Jing (Essence), 10–11
joy, Heart and, 6
‘jump and shout’ response, 192
M
magnetic resonance imaging (MRI)
in multiple sclerosis, 139
in stroke, 102
in transverse myelitis, 157
‘man in the ear’, 188, 188f
management of neurological conditions,
41–42
McGill Short Form Pain Score, 166
Measure Yourself Medical Outcome
Profile-2 (MYMOP-2), 202
mechanisms of action, 54–55
extrasegmental and central regulatory
effects, 55
local effects, 55
myofascial trigger points, 55
segmental effects, 55
medical model of health care, 40
menstrual cramps, 26
Mental Capacity Act 2005 (England
and Wales), 44
Middle Jiao (Chamber of Ripening
Maceration), 14
Mind (Shen), 6
models of health care, 40
Modified Ashworth Scale (MAS), 63
Modified Fatigue Impact Scale
(MFIS), 93

207
 Index

mood disturbance, 74–76 case study, 91–92 stage 3: Middle Jiao involvement,
acupuncture for, 75–76 bowel problems, 68 144
management, 75 case studies, 147–149, 149t stage 3.1: Spleen Qi Xu, 144–145
in neurological conditions, 75 cognitive loss, 140 stage 4: Kidney Xu, 145, 146f
physiotherapy, 47 constipation in, case study, 92 surgery, 139
prevalence, 75t definition, 138 symptom picture, 141t
Motor Assessment Scale (MAS), 202 depression, 140 symptoms, 23
Motor Dysfunction Rating Scale for case study, 93–94 tests, 139
Parkinson’s Disease (MDRSPD), diagnosis, 138–139 useful points, 142t
128 differential diagnosis, 138–139 Wei Bi and, 20
motor dysfunction, 58–59, 61t emotional lability in, 6, 140 Multiple Sclerosis Impact Scale-29
motor function, 58 exercise programmes, 46 (MSIS-29), 202
motor neurone disease (MND), fatigue in, case study, 93 multiple-system atrophy, 126
173–184 ICF applied to, 41f ‘muscle sinews’, 19
acupuncture, 176–179 incidences, 138 Muscle/Spleen Bi, 19
body, 177 insomnia in, 72 myalgic encephalomyelitis (ME), 21
deficient Lung and Spleen Qi, 177 Liver and Kidney Yin deficiency, myasthenia gravis, 126
Qi and Blood deficient, 178–179 147 myoclonus, 63
scalp, 177 Liver Qi and, 9 myofascial pain, 26
TCM, 177–179, 179f Liver Qi Xu and, 21 myotome, 29
case studies, 179–183 medical treatment, 139
definition, 174 mortality, 138
diagnosis, 175 pain, 140–141
N
differential diagnosis, 175 mechanism, 57 National Acupuncture Detoxification
impact on the patient, 175–176 musculoskeletal, 140 Association, 191
breathing problems, 176 neuropathic, 140 National Institutes of Health List 1998,
constipation, 176 nociceptive, case study, 84–86 26–27
dysarthria, 176 pharmacology, 139 nausea, 13
fatigue, 176 Phlegm Heat agitating Wind postoperative and chemotherapy, 26
impaired swallowing, 176 (affecting Liver), 146–147 needles, sham, 34
insomnia, 176 physiotherapy, 140–141 neurofacilitation, 44
pain, 175 ataxia and tremor, 140 neurological conditions, problems
incidence, 174 contractures affecting joints, 140 researching, 35–36
medical treatment, 175 fatigue, 140 neurological physiotherapy, 44–47
mortality, 174 sensory losses, including visual acupuncture within, 48
pharmacology, 175 problems, 140 assessment, 45
physiotherapy, 176 spasticity and spasms, 140 activity, 45
prognosis, 175–176 weakness and cardiorespiratory body structure/function, 45
risk factors, 175 fitness, 140 context, 45
surgery, 175 prognosis, 139–140 participation, 45
tests, 175 Qi and blood deficiency in, 146 focus of treatment, 45f
useful points, 178t risk factors, 138 historical development, 44
Motricity Index (MI), 107, 202 Skin/Lung Bi and, 19–20 interventions, 45–47
moving cupping, 155, 196, 196f sleep quality, 46–47 sensorimotor system, 45–46
Multidimensional Fatigue Inventory spasticity in legs affecting walking in, functional ability, 46
(MFI), 202 case study, 90–91 secondary complications, 46
multiple sclerosis (MS), 35 staging, 143t, 145f self-efficacy, 47
acupuncture research, 141 stage 1: remission, 143–144 symptoms, 46–47
acupuncture treatment, 58, 141–146 stage 2: external channel problem, multidisciplinary team, 44–45
body, 141 144 provide support, 47
scalp, 141–143 stage 2: mving inwards (Damp heat neurological (neurology) syndrome, 22,
TCM approach, 143–144 invades and obstructuts 197–199, 198f
anxiety in, 140 channels), 144, 144t symptoms, 23t
bladder dysfunction in, 66 stage 3: Liver Blood Xu, 145 neuropathic pain, 32, 56

208

acupuncture, evidence for use, 58
clinical examples, 57t
definition, 57t
mechanisms, 56–58
neurosyndrome, 15
Nine-Hole Peg test, 112
nociceptive pain, 32, 56
clinical examples, 57t
definition, 57t
in multiple sclerosis case study,
84–86
Nottingham Health Profile, 107–108
NSAIDs, 175
Numerical Rating Scale (NRS), 202
Nutritive Essence, 9–10
O Phlegm Heat agitating Wind
OAB syndrome, 66–68
electrical stimulation, 68
osteoarthritis, 26
osteoporosis, 18
overactive bladder (OAB), 55
oxybutynin, 68
P surgery, 127
pain
in Brown-Séquard syndrome,
case study, 86
in motor neurone disease, 175
physiotherapy, 46
prevalence, 56t
in spinal cord injury, 154
see also central poststroke pain
(CPSP); neuropathic pain;
nociceptive pain; phantom
limb pain
painful Bi, 17
painful obstruction syndrome, 16
paraesthesia, 58
acupuncture for, 58, 61t
in transverse myelitis, case study,
86–87
Parkinsonian dyskinesia, 63–66
acupuncture for, 65–66, 65t
prevalence, 63–64
Parkinson’s disease, 9, 20, 22, 35
acupuncture, 129–132
body, 129
for pain, 58
scalp, 129–131, 131f
TCM approach, 131–132
bladder dysfunction in, 66
Index
bowel problems, 68 in cerebral palsy, 116–117
case study, 91, 133–134 in Guillain-Barré syndrome, 163
diagnosis, 126–127 key principles, 44–47
differential diagnosis, 126–127 in motor neurone disease, 176
dyskinaesia and ‘off’ symptoms in, in multiple sclerosis, 140–141
case study, 91 in Parkinson’s disease, 128
impact on patient, 127–128 in spinal cord injury, 153–155
incidence, 126 in spinal stroke, 159
insomnia in, 72 in stroke, 106–108
Liver and Kidney Yin deficiency, in transverse myelitis, 158
132–133 in traumatic brain injury, 119
treatment, 133 see also physiological physiotherapy
medical treatment, 127 Pittsburgh Sleep Quality Inventory
mortality, 126 (PSQI), 203
options to enhance, 47 poliomyelitis, infantile, 20
pain mechanism, 58 polymyositis, 126
pharmacology, 127 posterior circulation infarcts
(POCIs), 102
(affecting Liver), 132 postherpetic neuralgia, 169
treatment, 132 acupuncture research, 169
physiotherapy, 128 acupuncture treatment, 169–170
prognosis, 127–128 case study, 170
Qi and blood deficiency, 132 pressure sores, 140–141, 153
treatment, 132 prevalence of neurological
risk factors, 126 conditions, 40
self-efficacy in, 47 primary lateral sclerosis, 174
progressive bulbar palsy (PBP), 174
symptom picture, 129t progressive muscular atrophy
tests, 127 (PMA), 174
useful points, 130t progressive supranuclear palsy, 126
Parkinson’s Disease Questionnaire-39
(PDQ-39), 202–203
partial anterior circulation infarcts Q
(PACIs), 101–102 quinine, 175
Pathogen Damp, 10
Pathogen Heat, 14
percutaneous electrical nerve R
stimulation (PENS), 58, 68 randomized controlled clinical trials
Pericardium (Xin Bao) (Heart (RCTs), 25–26, 27, 28, 34
Protector), 5, 7, 12 construction, 28
peripheral neuropathies German, 28
acupuncture for, 58, 59t rasagiline (Agilect), 127
pain mechanism, 56 referred pain patterns, 34
useful points, 165t rehabilitation
phantom limb pain, 170 evidence-based practice, 43
acupuncture, 171 general principles, 42
mechanism, 170 goal-setting, 43
treatment, 171 key aspects, 42–43
phenol nerve blocks, 63 outcome measures, 43
phenytoin, 175 person-centred service, 42
Phlegm Fire, 14 ‘slinky’ model of rehabilitation, 42f
physiology, origins of, 5–12 specialist multidisciplinary team,
physiotherapy, 56 42–43
in Bell’s palsy, 167–168 research protocols, 34–35
209
 Index

restless-legs syndrome (RLS), 169 prevalence, 63 cost, 100

acupuncture, 169 in spinal cord injury, 153 CT and MRI scans, 102
symptoms, 169 spinal cord injury (SCI), 152 definition, 100
rheumatoid arthritis, 28 acupuncture, 155–156 diagnosis, 101–102
riluzole, 175 body, 155 incidence, 40, 100
‘Ringing the Dragon’, 170 for pain, 58, 60t insomnia in, 72
rotenone, 129 scalp, 155 medical treatment, 102–104
TCM approach, 155–156 acute, 102–103
anterior cord syndrome, 152 management and rehabilitation,
S bowel problems, 68 103–104
Sanjiao (Triple Energizer; TE), 5, definition, 152 subacute, 103
14–15 diagnosis and prognosis, 152–153 mortality, 100–101
Scale of Pain Intensity (SPIN), 203 early interventions, 153 pain mechanism, 57
scalp acupuncture, 194–195 incidence and mortality, 152 patterns of recovery, 105
clinical reasoning, 195 medical treatment, 153 physiotherapy, 106–108
contraindications, 194 pain mechanism, 57 acupuncture and, 106
Jiao’s sytem, 194 partial, case study, 156–157 blood composition, velocity and
in motor neurone disease, 177 pharmacology, 153 general circulation, 106
in multiple sclerosis, 141–143 physiotherapy, 153–155 cerebral circulation, 106
in Parkinson’s disease, 129–131, 131f rehabilitation, 154t current, 106
research, 195 risk factors, 152 effects on energy levels, 107–108
in spinal cord injury, 155 surgery, 153 effects on mood, 107
schizophrenia, 13 useful points, 156t effects on muscle tissue, 107
sciatica, 18–19 spinal stroke, 158 neurological basis, 106–108
sclerotome, 29 acupuncture, 159 prognosis, 104–106
segmental innervation of muscles, 30t aetiology, 158 body structure and function,
segmental needling, 29 clinical presentation, 158–159 activity and participation, 104
self-efficacy, 44 definition, 158 effects, 104–105
physiotherapy and, 47 incidence, 158 recurrence, 106
in stroke, 47 mortality, 158 rehabilitation, 26
sensory function, 55 physiotherapy, 159 risk factors, 101
abnormal sensations, 56 prognosis, 159 self-efficacy in, 47
absent or impaired sensation, 55 treatment, 159 syndromes identified in,
impaired sensation useful points, 156t 109–110, 110t
acupuncture for, 55 Spiritual Pivot, 12 TCM and, 108–109, 109t
prevalence, 55 Spleen (Pi), 9–10 acupuncture formula for
nociceptive pain vs neuropathic splenectomy, 9 windstroke sequelae, 109
pain, 56 stagnation, 15 lower-limb points, 109
see also pain, paraesthesia Standards for Reporting Interventions in upper-limb points, 109
sensory function, 84 Controlled Trials of Acupuncture urinary problems, 66
Shen, 4 (STRICTA) guidelines, 27 subdural haematoma, 100
Shen Nong, 5 ‘stirring of the inner Wind of the Liver’, 9 swallowing, impaired
Shy-Drager syndrome, 126 Stomach (Wei) (Chamber of in motor neurone disease, 176
diagnosis, 128 Maceration), 13–14 in multiple sclerosis, 140
types, 126 stress incontinence, 66 symptom relationships in neurological
silent infarcts, 102 stroke, 35, 100 conditions, 75f
Skin/Lung Bi, 19–20 acupuncture
sleep disturbance see insomnia points in, 111t
Small Intestine (Xiao Chang), 12 rationale for treatment, 115
T
spastic hypertonia, 105 treatment, 114t tendinomuscular meridians, 19
spasticity, 58, 62–63 bladder dysfunction in, 66 Tendon/Liver Bi, 18–19
acupuncture for, 63, 64t bowel problems in, 68 tennis elbow, 26
management, 63 case studies, 88, 89–90, 94–95, terror, 11–12
in multiple sclerosis, case study, 90–91 112–115 tissue plaminogen activator (tPA), 103

210
 Index

tizanidine, 175 pain mechanism, 57 W

tolterodine, 68 physiotherapy and, 119
tongue coating, 14 prognosis, 119 wandering (migratory) Bi, 16
total anterior circulation infarct symptoms, 119 weakness and paralysis, 60–62
(TACI), 101 trigger point acupuncture, acupuncture for, 60–62
traditional Chinese medicine (TCM), 4 192–193 Wei Bi (atrophy syndrome), 20–22, 21f
transcutaneous electrical nerve deep trigger point needling, Wei Qi (Defensive Qi), 8
stimulation (TENS), 46, 56, 194 192–193 Wei syndrome, 15, 177
electrical stimulation, 68 superficial needling, 192 Western medical acupuncture
in stroke, 106 application, 54
transient ischaemic attack (TIA), approach, 187–188
100, 101
U definition, 26–27
transverse myelitis, 157 Unified Parkinson’s Disease Rating supporting techniques, 188–195
acupuncture, 158 Scale (UPDRS), 128 whiplash syndrome, 18
TCM, 158 Upper Jiao (chamber of mist), 14 wind invasion (Wind Bi), 16
case study, 86–87 urge incontinence, 66–68 suggested points, 17
definition, 157 Urinary Bladder (Pang Guan), 14 World Health Organization, 27, 104
diagnosis, 157 urinary incontinence see bladder worry, 11–12
differential diagnosis, 157 dysfunction
impact on patient, 157 Uterus, 15
incidence and mortality, 157
Y
medical treatment, 157 Yamamoto New Scalp Acupuncture
physiotherapy, 158
V (YNSA), 155, 194
prognosis, 157 vascular parkinsonism, 126
risk factors, 157 vascular/Heart Bi, 19
tests, 157 visceral dysfunction, 91
Z
useful points, 156t visceral function, 66 Zang Fu organs, 5–12, 5t, 18
traumatic brain inury, 118 visual analogue scale (VAS), 112, 203 Bi syndrome associated with, 18–20
acupuncture and, 58, 119–120 Voita method, 117 in neurology, 15
case study, 94, 120 vomiting, 13 zoplicone, 72
insomnia in, 72 postoperative and chemotherapy, 26 Zusanli Stomach 36, 13

211